StockData
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc. (MIST) stock

MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.40−0.06 (-13.27%)

Close on Nov 19, 2026Market cap $49.71MP/E –Yield –

Milestone Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$527.00K–
Q1 FY2026Mar 31, 2026$224.00K–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0–

More Milestone Pharmaceuticals figures

See a number that looks wrong?